Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

436 studies match

clinicaltrialsPublishedShowing 251–300 of 436 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06926868	A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)	recruiting	Phase 2 / Phase 3	600	Bristol-Myers SquibbINDUSTRY	28	Aug 10, 2026	clinicaltrials
NCT07098988	Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC	recruiting	Phase 2	107	CatalYm GmbHINDUSTRY	7